| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1489117 | Materials Research Bulletin | 2012 | 9 Pages |
We report a new magnetic nanohybrid material to make layered double hydroxides (LDHs) as a targeted drug carrier. The magnetite prepared using a modified conventional coprecipitation technique was embedded in to the fluvastatin intercalated hydrophobic anionic clay through one step process. XRD analysis shows a decrease in lattice parameter of magnetite which is due to generation of stress by the LDHs. Filtered HRTEM image indicates that the magnetic nanohybrid consists of well-defined composite structure and the diameter is around 13 nm. Further, it is shown through magnetisation and ESR study that the exchange interaction between magnetite and drug intercalated LDHs layers shifted the TB of Fe3O4 in magnetic nanohybrid to lower temperatures. In vitro release study of nanohybrid particles at pH 7.4 in PBS and at 37 °C show a faster release for magnetic nanohybrids. The mechanism is probably due to combined effect of interparticle and heterogeneous diffusion via anionic exchange.
Graphical abstractA new magnetic nanohybrid material consists of well defined composite structure and the diameter is around 13 nm which is sum of the diameter of magnetite and the thickness of exfoliated LDHs monolayers.Figure optionsDownload full-size imageDownload as PowerPoint slideHighlights► A new magnetic nanohybrid material to make LDHs as a targeted drug carrier. ► HRTEM image clearly indicates that the magnetic nanohybrid consists of composite structure. ► Release study shows a faster release for magnetic nanohybrids. ► Drug release is due to combined effect of interparticle and heterogeneous diffusion.
